<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2017-04-12" version="152">
<accession>Q15126</accession>
<accession>Q5TZW9</accession>
<name>PMVK_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphomevalonate kinase</fullName>
<shortName>PMKase</shortName>
<shortName>hPMK</shortName>
<ecNumber>2.7.4.2</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">PMVK</name>
<name type="synonym">PMKI</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="17330" last="17334">
<title>Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence.</title>
<authorList>
<person name="Chambliss K.L."/>
<person name="Slaughter C.A."/>
<person name="Schreiner R."/>
<person name="Hoffmann G.F."/>
<person name="Gibson K.M."/>
</authorList>
<dbReference type="PubMed" id="8663599"/>
<dbReference type="DOI" id="10.1074/jbc.271.29.17330"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT MET-125</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skin</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="J. Lipid Res." volume="40" first="672" last="679">
<title>Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting.</title>
<authorList>
<person name="Olivier L.M."/>
<person name="Chambliss K.L."/>
<person name="Gibson K.M."/>
<person name="Krisans S.K."/>
</authorList>
<dbReference type="PubMed" id="10191291"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 33-192</scope>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="J. Lipid Res." volume="38" first="2216" last="2223">
<title>Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways.</title>
<authorList>
<person name="Hinson D.D."/>
<person name="Chambliss K.L."/>
<person name="Toth M.J."/>
<person name="Tanaka R.D."/>
<person name="Gibson K.M."/>
</authorList>
<dbReference type="PubMed" id="9392419"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Biochemistry" volume="45" first="3235" last="3242">
<title>Phosphomevalonate kinase: functional investigation of the recombinant human enzyme.</title>
<authorList>
<person name="Herdendorf T.J."/>
<person name="Miziorko H.M."/>
</authorList>
<dbReference type="PubMed" id="16519518"/>
<dbReference type="DOI" id="10.1021/bi052231u"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-17; ARG-18; LYS-19; LYS-22 AND ASP-23</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ATP-BINDING</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Biochemistry" volume="46" first="11780" last="11788">
<title>Functional evaluation of conserved basic residues in human phosphomevalonate kinase.</title>
<authorList>
<person name="Herdendorf T.J."/>
<person name="Miziorko H.M."/>
</authorList>
<dbReference type="PubMed" id="17902708"/>
<dbReference type="DOI" id="10.1021/bi701408t"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-48; LYS-69; ARG-73; ARG-84; ARG-110; ARG-111 AND ARG-141</scope>
<scope>ATP-BINDING</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2015" name="Elife" volume="4" first="E06322" last="E06322">
<title>Genomic variations of the mevalonate pathway in porokeratosis.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Li C."/>
<person name="Wu F."/>
<person name="Ma R."/>
<person name="Luan J."/>
<person name="Yang F."/>
<person name="Liu W."/>
<person name="Wang L."/>
<person name="Zhang S."/>
<person name="Liu Y."/>
<person name="Gu J."/>
<person name="Hua W."/>
<person name="Fan M."/>
<person name="Peng H."/>
<person name="Meng X."/>
<person name="Song N."/>
<person name="Bi X."/>
<person name="Gu C."/>
<person name="Zhang Z."/>
<person name="Huang Q."/>
<person name="Chen L."/>
<person name="Xiang L."/>
<person name="Xu J."/>
<person name="Zheng Z."/>
<person name="Jiang Z."/>
</authorList>
<dbReference type="PubMed" id="26202976"/>
<dbReference type="DOI" id="10.7554/eLife.06322"/>
</citation>
<scope>INVOLVEMENT IN POROK1</scope>
<scope>VARIANT POROK1 GLU-69</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proteins" volume="73" first="254" last="258">
<title>Crystal structure of human phosphomevalonate kinase at 1.8 A resolution.</title>
<authorList>
<person name="Chang Q."/>
<person name="Yan X.-X."/>
<person name="Gu S.-Y."/>
<person name="Liu J.-F."/>
<person name="Liang D.-C."/>
</authorList>
<dbReference type="PubMed" id="18618710"/>
<dbReference type="DOI" id="10.1002/prot.22151"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS)</scope>
<scope>ATP-BINDING</scope>
<scope>SUBSTRATE BINDING</scope>
</reference>
<comment type="catalytic activity">
<text evidence="9">ATP + (R)-5-phosphomevalonate = ADP + (R)-5-diphosphomevalonate.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="5 10">25 uM for (R)-5-phosphomevalonate</KM>
<KM evidence="5 10">0.26 mM for ATP</KM>
<Vmax evidence="5 10">46.4 umol/min/mg enzyme with (R)-5-phosphomevalonate as substrate</Vmax>
<Vmax evidence="5 10">52 umol/min/mg enzyme with ATP as substrate</Vmax>
</kinetics>
</comment>
<comment type="pathway">
<text>Isoprenoid biosynthesis; isopentenyl diphosphate biosynthesis via mevalonate pathway; isopentenyl diphosphate from (R)-mevalonate: step 2/3.</text>
</comment>
<comment type="subunit">
<text evidence="2">Monomer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Peroxisome</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="9">Heart, liver, skeletal muscle, kidney, and pancreas. Lower level in brain, placenta and lung.</text>
</comment>
<comment type="induction">
<text evidence="4">By sterol.</text>
</comment>
<comment type="disease" evidence="8">
<disease id="DI-04570">
<name>Porokeratosis 1, multiple types</name>
<acronym>POROK1</acronym>
<description>A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported.</description>
<dbReference type="MIM" id="175800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<dbReference type="EC" id="2.7.4.2"/>
<dbReference type="EMBL" id="L77213">
<property type="protein sequence ID" value="AAC37593.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019976">
<property type="protein sequence ID" value="AAV38779.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006089">
<property type="protein sequence ID" value="AAH06089.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007694">
<property type="protein sequence ID" value="AAH07694.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF026069">
<property type="protein sequence ID" value="AAC60791.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1073.1"/>
<dbReference type="RefSeq" id="NP_006547.1">
<property type="nucleotide sequence ID" value="NM_006556.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.30954"/>
<dbReference type="PDB" id="3CH4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="B=1-192"/>
</dbReference>
<dbReference type="PDBsum" id="3CH4"/>
<dbReference type="ProteinModelPortal" id="Q15126"/>
<dbReference type="SMR" id="Q15126"/>
<dbReference type="BioGrid" id="115897">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="IntAct" id="Q15126">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="MINT" id="MINT-7034566"/>
<dbReference type="STRING" id="9606.ENSP00000357452"/>
<dbReference type="GuidetoPHARMACOLOGY" id="641"/>
<dbReference type="SwissLipids" id="SLP:000001241"/>
<dbReference type="iPTMnet" id="Q15126"/>
<dbReference type="PhosphoSitePlus" id="Q15126"/>
<dbReference type="BioMuta" id="PMVK"/>
<dbReference type="DMDM" id="3024422"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00220648"/>
<dbReference type="EPD" id="Q15126"/>
<dbReference type="PaxDb" id="Q15126"/>
<dbReference type="PeptideAtlas" id="Q15126"/>
<dbReference type="PRIDE" id="Q15126"/>
<dbReference type="DNASU" id="10654"/>
<dbReference type="Ensembl" id="ENST00000368467">
<property type="protein sequence ID" value="ENSP00000357452"/>
<property type="gene ID" value="ENSG00000163344"/>
</dbReference>
<dbReference type="GeneID" id="10654"/>
<dbReference type="KEGG" id="hsa:10654"/>
<dbReference type="CTD" id="10654"/>
<dbReference type="DisGeNET" id="10654"/>
<dbReference type="GeneCards" id="PMVK"/>
<dbReference type="HGNC" id="HGNC:9141">
<property type="gene designation" value="PMVK"/>
</dbReference>
<dbReference type="HPA" id="HPA029900"/>
<dbReference type="MalaCards" id="PMVK"/>
<dbReference type="MIM" id="175800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607622">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15126"/>
<dbReference type="OpenTargets" id="ENSG00000163344"/>
<dbReference type="PharmGKB" id="PA33465"/>
<dbReference type="eggNOG" id="ENOG410IZWN">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111IXB">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000014801"/>
<dbReference type="HOGENOM" id="HOG000261666"/>
<dbReference type="HOVERGEN" id="HBG003277"/>
<dbReference type="InParanoid" id="Q15126"/>
<dbReference type="KO" id="K13273"/>
<dbReference type="OMA" id="KNDIKWF"/>
<dbReference type="OrthoDB" id="EOG091G0PNO"/>
<dbReference type="PhylomeDB" id="Q15126"/>
<dbReference type="TreeFam" id="TF312935"/>
<dbReference type="BioCyc" id="MetaCyc:HS08830-MONOMER"/>
<dbReference type="BRENDA" id="2.7.4.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-191273">
<property type="pathway name" value="Cholesterol biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2426168">
<property type="pathway name" value="Activation of gene expression by SREBF (SREBP)"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q15126"/>
<dbReference type="UniPathway" id="UPA00057">
<property type="reaction ID" value="UER00099"/>
</dbReference>
<dbReference type="ChiTaRS" id="PMVK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q15126"/>
<dbReference type="GenomeRNAi" id="10654"/>
<dbReference type="PRO" id="PR:Q15126"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163344"/>
<dbReference type="CleanEx" id="HS_PMVK"/>
<dbReference type="ExpressionAtlas" id="Q15126">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15126">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005777">
<property type="term" value="C:peroxisome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004631">
<property type="term" value="F:phosphomevalonate kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006695">
<property type="term" value="P:cholesterol biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019287">
<property type="term" value="P:isopentenyl diphosphate biosynthetic process, mevalonate pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070723">
<property type="term" value="P:response to cholesterol"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016126">
<property type="term" value="P:sterol biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR005919">
<property type="entry name" value="Pmev_kin_anim"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13101">
<property type="entry name" value="PTHR13101"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04275">
<property type="entry name" value="P-mevalo_kinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF036639">
<property type="entry name" value="PMK_anim"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01223">
<property type="entry name" value="Pmev_kin_anim"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0152">Cholesterol biosynthesis</keyword>
<keyword id="KW-0153">Cholesterol metabolism</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0576">Peroxisome</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0752">Steroid biosynthesis</keyword>
<keyword id="KW-0753">Steroid metabolism</keyword>
<keyword id="KW-0756">Sterol biosynthesis</keyword>
<keyword id="KW-1207">Sterol metabolism</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Phosphomevalonate kinase" id="PRO_0000058472">
<location>
<begin position="1"/>
<end position="192"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12 14">
<location>
<begin position="17"/>
<end position="23"/>
</location>
</feature>
<feature type="short sequence motif" description="Microbody targeting signal" evidence="3">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="13 14">
<location>
<position position="141"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="7">
<location>
<position position="170"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="14">
<location>
<position position="171"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="14">
<location>
<position position="176"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="14">
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In POROK1; unknown pathological significance." id="VAR_075051" evidence="8">
<original>K</original>
<variation>E</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16836525." id="VAR_051283" evidence="11">
<original>V</original>
<variation>M</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 8-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in Km for MgATP and R-MVP." evidence="5">
<original>K</original>
<variation>M</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 85-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in Km for MgATP and R-MVP." evidence="5">
<original>R</original>
<variation>Q</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 9-fold decrease in Vmax for MgATP and R-MVP. Approximately 10-fold increase in Km for MgATP and R-MVP." evidence="5">
<original>K</original>
<variation>M</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 100000-fold decrease in Vmax for MgATP." evidence="5">
<original>K</original>
<variation>M</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 7-fold decrease in Vmax for MgATP and R-MVP. Approximately 10-fold increase in Km for MgATP and 5-fold increase in Km for R-MVP." evidence="5">
<original>D</original>
<variation>N</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 1400-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in Km for MgATP and R-MVP." evidence="6">
<original>K</original>
<variation>M</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 500-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in Km for MgATP and R-MVP." evidence="6">
<original>K</original>
<variation>M</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 3000-fold decrease in Vmax for MgATP and R-MVP. No change in Km for MgATP and approximately 3-fold increase in Km for R-MVP." evidence="6">
<original>R</original>
<variation>M</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 10-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in Km for MgATP and 50-fold increase in Km for R-MVP." evidence="6">
<original>R</original>
<variation>M</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost no change in Km and Vmax for MgATP and R-MVP.">
<original>R</original>
<variation>M</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 20000-fold decrease in Vmax for MgATP." evidence="6">
<original>R</original>
<variation>M</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 65-fold decrease in Vmax for MgATP and R-MVP. Approximately 8-fold increase in Km for MgATP and 60-fold increase in Km for R-MVP." evidence="6">
<original>R</original>
<variation>M</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 4-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in Km for MgATP and R-MVP.">
<original>R</original>
<variation>M</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 3-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in Km for MgATP and no change in Km for R-MVP.">
<original>R</original>
<variation>M</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="mutagenesis site" description="Approximately 15-fold decrease in Vmax for MgATP and R-MVP. Approximately 50-fold increase in Km for MgATP and approximately 7-fold in Km for R-MVP." evidence="6">
<original>R</original>
<variation>M</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="9"/>
<end position="16"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="22"/>
<end position="33"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="44"/>
<end position="53"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="72"/>
<end position="86"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="102"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="112"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="126"/>
<end position="133"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="140"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="147"/>
<end position="151"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="153"/>
<end position="156"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="157"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="174"/>
<end position="189"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CH4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10191291"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16519518"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17902708"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18618710"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26202976"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8663599"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9392419"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="12" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16519518"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17902708"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18618710"/>
</source>
</evidence>
<sequence length="192" mass="21995" checksum="D7E720D0DDCCA249" modified="2007-01-23" version="3">
MAPLGGAPRLVLLFSGKRKSGKDFVTEALQSRLGADVCAVLRLSGPLKEQYAQEHGLNFQ
RLLDTSTYKEAFRKDMIRWGEEKRQADPGFFCRKIVEGISQPIWLVSDTRRVSDIQWFRE
AYGAVTQTVRVVALEQSRQQRGWVFTPGVDDAESECGLDNFGDFDWVIENHGVEQRLEEQ
LENLIEFIRSRL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>